Jorge DiMartino
Director/Board Member presso Gotham Therapeutics Corp.
Patrimonio netto: 409 820 $ in data 31/03/2024
Profilo
Jorge DiMartino is currently a Director at Gotham Therapeutics Corp.
Prior to this, he was the Chief Medical Officer & EVP-Clinical Development at Kronos Bio, Inc. from 2019 to 2024.
Before that, he served as Vice President-Translational Development Oncology at Celgene Corp.
from 2014 to 2019.
He also worked as a Group Medical Director at Genentech, Inc. Additionally, he holds a doctorate degree from both the University of California San Diego and Cornell University Graduate School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
KRONOS BIO INC
0.52% | 04/01/2024 | 315 246 ( 0.52% ) | 409 820 $ | 31/03/2024 |
Posizioni attive di Jorge DiMartino
| Società | Posizione | Inizio |
|---|---|---|
Gotham Therapeutics Corp.
 Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Director/Board Member | - |
Precedenti posizioni note di Jorge DiMartino
| Società | Posizione | Fine |
|---|---|---|
| KRONOS BIO, INC. | Chief Tech/Sci/R&D Officer | 16/02/2024 |
| CELGENE | Corporate Officer/Principal | 01/12/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Formazione di Jorge DiMartino
| University of California San Diego | Doctorate Degree |
| Cornell University Graduate School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KRONOS BIO, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Jorge DiMartino
